Friday, November 6, 2026
The Cancer News
AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER

Loan Retchless, ARNP
nurse practitioner
Loan Retchless, ARNP, is a nurse practitioner with American Oncology Network and served as session chair for a discussion on toxicities of novel anti-cancer therapy. Her clinical practice focuses on the ongoing management of ovarian cancer, including the difficult decisions that arise when a highly effective maintenance therapy produces a severe, treatment-limiting adverse event.
Published Articles (1)
When a PARP Inhibitor Works but the Body Cannot Tolerate It: Severe Niraparib Toxicity in BRCA1-Mutated Ovarian Cancer
November 3, 2026
Updated pooled analyses of niraparib maintenance trials continue to show a clear progression-free survival benefit, particularly in BRCA-mutated and HRD-positive ovarian cancer, without a corresponding overall survival advantage